Global Alprostadil Injection Market 2022-2030

    Multi User License - $3,999

    In Stock

    Coming Soon

    GLOBAL ALPROSTADIL INJECTION MARKET

     

    INTRODUCTION

    Men who suffer from erectile dysfunction, also known as sexual impotence, are treated with an injection of alprostadil.

     

    infographics; Alprostadil Injection Market ,
Alprostadil Injection Market  Size,
Alprostadil Injection Market  Trends, 
Alprostadil Injection Market  Forecast,
Alprostadil Injection Market  Risks,
Alprostadil Injection Market Report,
Alprostadil Injection Market  Share

     

    It is one of a class of drugs called vasodilators, which work by making blood vessels grow. Men who do not suffer from erectile dysfunction should not take Alprostadil as a sexual aid.

     

    Alprostadil can be used alone or in conjunction with other medical tests to diagnose erectile dysfunction that may be brought on by issues with the penis’ nerves or blood vessels. This medication is accessible just with your PCP’s remedy.

     

    GLOBAL ALPROSTADIL INJECTION MARKET SIZE AND FORECAST

     

    The Global Alprostadil injection market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2022 to 2030.

     

    MARKET DYNAMICS

    The US Food and Drug Administration has given Upjohn permission to sell Caverject Injection (alprostadil sterile powder) to diagnose and treat male erectile dysfunction resulting from neurologic, vascular, psychological, or mixed causes.

     

    Although other drugs have been used off-label for many years, this product is the first prescription medication for erectile dysfunction to be approved in the United States (see also pages 26-27).

     

    Caverject is injected into the corpus cavernosum with a small needle.

     

    Caverject can be self-administered by the patient at will after Upjohn suggests that patients selected for treatment receive initial injections from medically trained personnel to determine the optimal dosing.

     

    The company says the maximum dose shouldn’t be more than 60mcg.It comes in vials of 10mcg and 20mcg.

     

    The medication increases blood flow to the penis by relaxing smooth muscle.

     

    It is derived from the vasoactive agent prostaglandin E1, which has been used to treat conditions like congenital heart defects in premature babies for a long time (Upjohn already sells the drug under the brand name Prostin VR Pediatric for keeping arteries open during neonatal heart surgery).

     

    Papaverine, whether administered with or without phentolamine, is a common component of conventional intracavernosal injection therapy. In addition, papaverine acts as a smooth muscle relaxant.

     

    The product will be promoted to general practitioners and other health care providers. Upjohn likewise noticed that the item might be a valuable assistant to other symptomatic tests in the determination of erectile brokenness.

     

    COMPANY PROFILE

    • UNITED BIOTECH PVT.LTD.
    • 3S CORPORATION
    • V. S. HEALTHCARE
    • DHEER HEALTH CARE PRIVATE LIMITED.
    • ZYPHARS PHARMACEUTICS PVT. LTD.
    • Trumac Healthcare
    • Pfizer Ltd

     

    THIS REPORT WILL ANSWER FOLLOWING QUESTIONS

    1. What is the average cost per Global Alprostadil injection market right now and how will it change in the next 5-6 years?
    2. Average cost to set up a Global Alprostadil injection market in the US, Europe and China?
    3. How many Global Alprostadil injection market are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    4. What is happening in the overall public, globally?
    5. Cost breakup of a Global Alprostadil injection market and key vendor selection criteria
    6. Where is the Global Alprostadil injection market manufactured? What is the average margin per equipment?
    7. Market share of Global Alprostadil injection market manufacturers and their upcoming products
    8. The most important planned Global Alprostadil injection market in next 2 years
    9. Details on network of major Global Alprostadil injection market and pricing plans
    10. Cost advantage for OEMs who manufacture Global Alprostadil injection market in-house
    11. 5 key predictions for next 5 years in Global Alprostadil injection market
    12. Average B-2-B Global Alprostadil injection market price in all segments
    13. Latest trends in Global Alprostadil injection market , by every market segment
    14. The market size (both volume and value) of Global Alprostadil injection market in 2022-2030 and every year in between?
    15. Global production breakup of Global Alprostadil injection market , by suppliers and their OEM relationship

     

     

     

    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2022-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2022-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2022-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2022-2030
    21 Product installation rate by OEM, 2022
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2022
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix

     

    0
      0
      Your Cart
      Your cart is emptyReturn to Shop